RNAseq of pancreata from KRasG12D/RosaMycER treated with Tamoxifen for different times
Ontology highlight
ABSTRACT: Experiment designed to study the effect of deregulated myc on pancreatic cancer progression and regression. In the KRasG12D/RosaMycER mouse model KRas and MycER are expressed exclusively in the pancreas, but MycER activity depends on Tamoxifen presence. RNAseq was preformed on pancreata from mice treated with Tamoxifen as follows: 1- Normal food. 2- Tamoxifen food 2 weeks. 3- Tamoxifen food 2 weeks, followed by normal food 1 day. 4- Tamoxifen food 2 weeks, followed by normal food 3 days.
INSTRUMENT(S): NextSeq 500
ORGANISM(S): Mus musculus
SUBMITTER: Tania Campos
PROVIDER: E-MTAB-8467 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA